AMLX - CIK 0001658551
Amylyx Pharmaceuticals, Inc. has filed 403 documents with the SEC between 2015 and 2026. The most frequent type is insider trade (160 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Filing | Type | Filed | Period covered |
|---|---|---|---|
| Passive ownership stake (update) | SC 13G/A | 2024-02-14 | - |
| Passive ownership stake (update) | SC 13G/A | 2024-02-13 | - |
| Passive ownership stake | SC 13G | 2024-01-29 | - |
| Insider trade | 4 | 2024-01-29 | 2024-01-25 |
| Insider trade | 4 | 2024-01-18 | 2024-01-16 |
| Insider trade | 4 | 2024-01-11 | 2024-01-09 |
| Insider trade | 4 | 2024-01-11 | 2024-01-09 |
| Insider trade | 4 | 2024-01-11 | 2024-01-09 |
| Insider trade | 4 | 2024-01-11 | 2024-01-09 |
| Insider trade | 4 | 2023-12-29 | 2023-12-27 |
| SEC correspondence | UPLOAD | 2023-12-20 | - |
| Company correspondence | CORRESP | 2023-12-19 | - |
| Insider trade | 4 | 2023-12-19 | 2023-12-15 |
| Passive ownership stake | SC 13G | 2023-12-11 | - |
| Major company event | 8-K | 2023-12-07 | 2023-12-07 |
| SEC correspondence | UPLOAD | 2023-12-05 | - |
| Insider trade | 4 | 2023-11-29 | 2023-11-27 |
| New insider ownership | 3 | 2023-11-29 | 2023-11-27 |
| Insider trade | 4 | 2023-11-20 | 2023-11-16 |
| Quarterly report | 10-Q | 2023-11-09 | 2023-09-30 |
| Major company event | 8-K | 2023-11-09 | 2023-11-09 |
| Insider trade | 4 | 2023-11-02 | 2023-10-31 |
| Major company event | 8-K | 2023-10-13 | 2023-10-13 |
| Activist ownership stake (update) | SC 13D/A | 2023-10-04 | - |
| Insider trade | 4 | 2023-08-24 | 2023-08-23 |
| Activist ownership stake (update) | SC 13D/A | 2023-08-17 | - |
| Insider trade | 4 | 2023-08-17 | 2023-08-15 |
| Insider trade | 4 | 2023-08-17 | 2023-08-15 |
| Insider sale notice | 144 | 2023-08-15 | - |
| Employee stock plan | S-8 | 2023-08-10 | - |
| Quarterly report | 10-Q | 2023-08-10 | 2023-06-30 |
| Major company event | 8-K | 2023-08-10 | 2023-08-10 |
| Major company event | 8-K | 2023-07-26 | 2023-07-26 |
| Insider trade | 4 | 2023-07-14 | 2023-07-12 |
| Major company event | 8-K | 2023-06-23 | 2023-06-23 |
| Insider trade | 4 | 2023-06-12 | 2023-06-08 |
| Insider trade | 4 | 2023-06-12 | 2023-06-08 |
| Insider trade | 4 | 2023-06-12 | 2023-06-08 |
| Insider trade | 4 | 2023-06-12 | 2023-06-08 |
| Major company event | 8-K | 2023-06-09 | 2023-06-08 |
| Passive ownership stake | SC 13G | 2023-06-09 | - |
| Insider trade | 4 | 2023-05-24 | 2023-05-22 |
| Insider trade | 4 | 2023-05-19 | 2023-05-17 |
| Insider trade | 4 | 2023-05-18 | 2023-05-16 |
| Insider trade | 4 | 2023-05-17 | 2023-05-15 |
| Insider sale notice | 144 | 2023-05-16 | - |
| Insider sale notice | 144 | 2023-05-15 | - |
| Quarterly report | 10-Q | 2023-05-11 | 2023-03-31 |
| Major company event | 8-K | 2023-05-11 | 2023-05-11 |
| Annual report to shareholders | ARS | 2023-04-27 | 2022-12-31 |